Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

All of them say "outperform" I think, which makes sence given the upside of even the more conservative estimates from this low level. This would be a ~$100 stock today with a current return of $2 per share if there was crystal clear clarity on future revenue streams.